| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9f8eff85227fd96744c754de382d6b2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-526
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2018-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0b8faa97b69b1cd0f498b898ee25f7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd92e68fb88e234235525dfcbbc0577d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24e889d3b98efa69fecebbec6099c827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbf30e1ed5468da514256aa956fc77e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9eccc76478c972a8c5d2c7692d28820
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68bc2aff48410ce6bbd1ff20d752f1d2 |
| publicationDate |
2020-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112020000209-A2 |
| titleOfInvention |
binding molecules that modulate a biological activity expressed by a cell |
| abstract |
the invention provides means and methods for inhibiting biological activity of cells. in one embodiment, the invention relates to a method of inhibiting biological activity in a first or second cell mediated by the binding of two membrane proteins that are binding partners with each other. the mentioned biological activity is inhibited by providing cells with an antibody or antibody-like molecule that can bind to each of the mentioned binding partners and the binding blocks the binding of the two binding partners, thereby inhibiting the mentioned biological activity. |
| priorityDate |
2017-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |